These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26592504)

  • 1. Uterine adenosarcomas are mesenchymal neoplasms.
    Piscuoglio S; Burke KA; Ng CK; Papanastasiou AD; Geyer FC; Macedo GS; Martelotto LG; de Bruijn I; De Filippo MR; Schultheis AM; Ioris RA; Levine DA; Soslow RA; Rubin BP; Reis-Filho JS; Weigelt B
    J Pathol; 2016 Feb; 238(3):381-8. PubMed ID: 26592504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
    Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
    Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
    Momeni Boroujeni A; Kertowidjojo E; Wu X; Soslow RA; Chiang S; Da Silva EM; Weigelt B; Chui MH
    Mod Pathol; 2022 Nov; 35(11):1684-1694. PubMed ID: 36138078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
    Bean GR; Anderson J; Sangoi AR; Krings G; Garg K
    Mod Pathol; 2019 Feb; 32(2):280-289. PubMed ID: 30266945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.
    Geyer FC; Burke KA; Piscuoglio S; Ng CKY; Papanastasiou AD; Marchiò C; Selenica P; Edelweiss M; Murray MP; Brogi E; Soslow RA; Rubin BP; Norton L; Reis-Filho JS; Weigelt B
    Mol Oncol; 2017 Aug; 11(8):913-926. PubMed ID: 28267263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical determination of estrogen and progesterone receptor positivity in uterine adenosarcoma.
    Amant F; Schurmans K; Steenkiste E; Verbist L; Abeler VM; Tulunay G; De Jonge E; Massuger L; Moerman P; Vergote I
    Gynecol Oncol; 2004 Jun; 93(3):680-5. PubMed ID: 15196864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine Adenosarcoma.
    Pinto A; Howitt B
    Arch Pathol Lab Med; 2016 Mar; 140(3):286-90. PubMed ID: 26927725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup.
    Lee JC; Lu TP; Changou CA; Liang CW; Huang HN; Lauria A; Huang HY; Lin CY; Chiang YC; Davidson B; Lin MC; Kuo KT
    Mod Pathol; 2016 Sep; 29(9):1070-82. PubMed ID: 27255164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.
    Yoon JY; de Kock L; Stewart CJR; McCluggage WG; Foulkes WD; Clarke BA; Rouzbahman M
    Cancer Treat Res Commun; 2021; 27():100363. PubMed ID: 33838572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis.
    Ngo C; Cotteret S; Deneche I; Kfoury M; Chehab R; Tran-Dien A; Vibert J; Leary A; Gouy S; Maulard A; Morice P; Scoazec JY; Pautier P; Genestie C
    Hum Pathol; 2024 Jun; 148():14-22. PubMed ID: 38688412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma.
    Rabban JT; Devine WP; Sangoi AR; Poder L; Alvarez E; Davis JL; Rudzinski E; Garg K; Bean GR
    Histopathology; 2020 Jul; 77(1):100-111. PubMed ID: 31971278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma.
    de Kock L; Yoon JY; Apellaniz-Ruiz M; Pelletier D; McCluggage WG; Stewart CJR; Dickson BC; Rouzbahman M; Clarke BA; Foulkes WD
    Mod Pathol; 2020 Jun; 33(6):1207-1219. PubMed ID: 31900434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
    Soslow RA; Ali A; Oliva E
    Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of epidermal growth factor receptor, HER-2/Neu, p53, and Ki-67 antigen in uterine malignant mixed mesodermal tumors and adenosarcoma.
    Swisher EM; Gown AM; Skelly M; Ek M; Tamimi HK; Cain JM; Greer BE; Muntz HG; Goff BA
    Gynecol Oncol; 1996 Jan; 60(1):81-8. PubMed ID: 8557233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
    Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive screening for MED12 mutations in gynaecological mesenchymal tumours identified morphologically distinctive mixed epithelial and stromal tumours.
    Yuan CT; Huang WC; Lee CH; Lin MC; Lee CH; Kao YC; Huang HY; Kuo KT; Lee JC
    Histopathology; 2017 May; 70(6):954-965. PubMed ID: 28002623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mullerian adenosarcoma of the female genital tract.
    McCluggage WG
    Adv Anat Pathol; 2010 Mar; 17(2):122-9. PubMed ID: 20179434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted genomic analysis of Müllerian adenosarcoma.
    Howitt BE; Sholl LM; Dal Cin P; Jia Y; Yuan L; MacConaill L; Lindeman N; Kuo F; Garcia E; Nucci MR; Quade BJ
    J Pathol; 2015 Jan; 235(1):37-49. PubMed ID: 25231023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine Adenosarcoma: a Review.
    Nathenson MJ; Ravi V; Fleming N; Wang WL; Conley A
    Curr Oncol Rep; 2016 Nov; 18(11):68. PubMed ID: 27718181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
    Gallardo A; Prat J
    Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.